Abstract Library

#1300 Staging of Neuroendocrine Tumors: Value of Hybrid Imaging With 111In- Pentetreotide

Introduction: Neuroendocrine tumors (NET) are rare and can occur anywhere in the body. Ninety-eight percent of these tumors express the type 2 of somatostatin receptors, making possible the functional imaging of NET. 111In-labelled pentetreotide specifically binds to somatostatin receptors, with particular affinity to subtypes 2 and 5.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Khamla E

Authors: Ben Sellem D, Khamla E, Ben Slimene M,

Keywords: Neuroendocrine tumor,

#1299 Clinical Value of Somatostatin Receptor Scintigraphy in the Management of Medullary Thyroid Carcinoma

Introduction: Medullary Thyroid Carcinoma (MTC) is a rare form of thyroid cancer. It represents 5 to 10 % of these cancers. MTC grows from specialized thyroid cells called para-follicular cells, or C-cells that secrete a hormone called calcitonin. Its prognosis is usually good. Recurrences can occur, requiring lifelong surveillance.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Khamla E

Authors: Khamla E, Ben Sellem D, Ben Slimene M,

Keywords: Medullary Thyroid Carcinoma, Somatostatin Receptor Scintigraphy, Management ,